Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News Ludwig Enterprises Inc (ID) LUDG

Healthcare Medical Care Medical Devices
Ludwig Enterprises, Inc. operates as a genomic technology and health related company in the United States. The company engages in the developing of products that use inflammatory genetic markers to assess the occurrence of inflammation and inflammation related diseases, as well as monitor treatment responses. It also provides Revealia for Life Home Test Kits, that identify the potential to... see more

Recent & Breaking News ()

Ludwig Enterprises Announces Publication of ASCO Abstract Detailing Novel Non-Invasive mRNA Signals that Scan for Breast Cancer

ACCESS Newswire May 29, 2025

Revealia Breast(TM) Offers Glimpse Into the Future of Early Cancer Detection With a Simple Cheek Swab

ACCESS Newswire May 7, 2025

Ludwig Enterprises Announces Two Abstracts Accepted for Publication in the Journal of Clinical Oncology

ACCESS Newswire April 29, 2025

Ludwig Enterprises Inc. Announces New Leadership Appointment of Charles T. Todd, Jr.

ACCESS Newswire April 23, 2025

Ludwig Enterprises Begins PCR Validation Test Process

ACCESS Newswire November 7, 2024

Ludwig Enterprises Files Provisional Patent for Revolutionary Cancer Screening Algorithm, Plans 2024 Launch as Revealia(TM)

ACCESS Newswire October 24, 2024

CORRECTING AND REPLACING: Ludwig Enterprises Inc. Announces AI-Powered Cancer Screening Technology

ACCESS Newswire September 24, 2024

Ludwig Enterprises Inc. Announces AI-Powered Cancer Screening Technology

ACCESS Newswire September 24, 2024

Ludwig Announces Acquisition of Intellectual Property and Patent

ACCESS Newswire September 17, 2024

Nova Mentis Assigns Intellectual Property

Newsfile August 27, 2024

Ludwig Announces Substantial Corporate Initiatives

ACCESS Newswire August 14, 2024

Ludwig Enterprises Files Provisional Patent on mRNA Genetic Screening Signals in Breast, Colon and Bladder Cancer

ACCESS Newswire July 9, 2024

Ludwig Enterprises Inc (OTC:LUDG) Funds Incurable Brain Cancer Study

ACCESS Newswire March 27, 2024

Ludwig Enterprises Inc (OTC:LUDG) Enters Booming Artificial Intelligence Cancer Screening Market with its Non-Invasive Cancer Diagnostics Testing Kit, launching within 2024

GlobeNewswire March 19, 2024

Ludwig Enterprises Inc. (OTC:LUDG) Announces Patent Filing for Breakthrough in Identifying mRNA Genes Associated with Certain Cancers

GlobeNewswire March 6, 2024

Ludwig Enterprises mRNA Bladder Cancer Study to be Launched

ACCESS Newswire January 31, 2024

Exousia AI Ludwig Enterprises Subsidiary Launches Liposome Research Program

ACCESS Newswire January 9, 2024

Ludwig Enterprises Appoints Scott Silverman as CFO

ACCESS Newswire November 16, 2023

Ludwig Enterprises Announces Effectiveness of Form S-1 Registration Application, Becomes an SEC Reporting Company

ACCESS Newswire November 14, 2023

Ludwig Enterprises, Inc. Announces Marvin S. Hausman, M.D. as Chief Executive Officer

ACCESS Newswire September 19, 2023

Podcasts